-
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Structured Evaluation of Oncology Real-World Data Quality for Practical Applications
Mar 10, 2025, 14:00 PM -
Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements
Mar 10, 2025, 14:00 PM -
Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM -
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Long-Term Survivorship
Mar 10, 2025, 14:00 PM -
Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results
Mar 10, 2025, 14:00 PM -
The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland
Mar 10, 2025, 14:00 PM -
Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)
Mar 10, 2025, 14:00 PM -
Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes
Mar 10, 2025, 14:00 PM -
Could Offering Physiotherapy Services in Emergency Departments Improve Patients’ Quality of Life While Reducing Healthcare Costs?
Mar 10, 2025, 14:00 PM -
A Simple and Practical Guide to Implementing Generalized Risk-Adjusted Cost-Effectiveness (GRACE): A Case Study in Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Impact of Single-Patient use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in the USA
Mar 10, 2025, 14:00 PM -
The Cost of 340B to States
Mar 10, 2025, 14:00 PM -
Characterizing the Experience of Excessive Daytime Sleepiness in Patients with Idiopathic Hypersomnia: Implications for Measuring Daytime Sleepiness with the Epworth Sleepiness Scale in a Clinical Trial (NCT05156047)
Mar 10, 2025, 14:00 PM -
Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023
Mar 10, 2025, 14:00 PM -
Expected vs. Observed Mortality Rates, Expressed As Number Needed to Treat, From a Phase 3 Clinical Trial Program of Patients With Hyperphagia and Prader-Willi Syndrome Treated With Diazoxide Choline Extended Release (DCCR)
Mar 10, 2025, 14:00 PM -
Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice
Mar 10, 2025, 14:00 PM
